Bio-Techne (TECH)
$60.36
0.98 (1.62%)
TECH Stock Quote Delayed 30 Minutes
TECH Stock Earnings: Bio-Techne Meets EPS, Misses Revenue for Q4 2024
TECH stock results show that Bio-Techne met analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$59.98
Market Cap
9.39B
PE Ratio
82.54
EPS
0.7313
Volume (Avg. Vol.)
1.89M
Day's Range
$58.97 - $60.36
52-Week Range
$56.60 - $85.30
Dividend & Yield
$0.32 (0.53%)
TECH Stock Predictions, Articles, and Bio-Techne News
TECH Stock Earnings: Bio-Techne Beats EPS, Beats Revenue for Q3 2024
TECH stock results show that Bio-Techne beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.
5G: Changing the Way We Live, Work, and Connect
The 5G revolution is unstoppable, and it will change our lives in many ways. Today, let's dive into the implications for connectivity and cloud-computing… and one of my favorite picks in the sector.
Demystifying 5G: 2 Reasons It Is Going to Change the World
5G is a quantum leap in communications technology; it replaces 4G like an automobile replaces a horse-drawn buggy, or like a personal computer replaces a slide rule...
The Trend Remains Supreme: 2 Stocks to Watch
The market is attempting to make a comeback. We’ve endured enough of the market’s gut punches this year, and now, as we – potentially, hopefully – begin to turn the corner and leave the lowest lows behind, it’s time to make pointed, intelligent investments. So, in this article, you’ll find two stocks I have on my watchlist for 2023 – and beyond.
Technology Never Sleeps
Tech stocks may slumber, but that certainly doesn’t deter from the overall strength and power of technology itself.
Cross This “Fad” Off Your Investment List
Fad investing and fad diets have one thing in common: They never last.
With Heady Days Behind It, Can a GoPro Stock Rally Last Into 2020?
Despite predictions of growth for the action camera market, the future looks like more of the same for GoPro stock.
DocuSign, Inc. (DOCU) Looking for New All-Time Highs
This morning, I am recommending a bullish trade on DocuSign, Inc. (NASDAQ:DOCU), the cloud-based software company.
Robust Earnings Momentum Metrics Drive Upgrade of Bio-Techne (TECH) to Buy
Portfolio Grader currently ranks Bio-Techne Corp (NASDAQ:TECH) a Buy. Using Louis Navellier's investing approach, this analytical tool evaluates stocks by employing proprietary fundamental and quantitative analytical tools. The shares have been upgraded from a Hold to a Buy in the last week.
